CR
Chandrawati Rai
About Chandrawati Rai
Data last updated:
Chandrawati Rai is a Director at Chandra Devbuild Private Limited (since 2015) and Director at Pharmaxy Medicines Private Limited (since 2023). The companies operate in Infrastructure and Utilities and Paper. The largest current company by reported revenue is Chandra Devbuild Private Limited at ₹9.27 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Chandra Devbuild Private Limited U45200MP2012PTC029779 | Director | 19 Oct 2015 | 2012 | ₹9.27 Cr (FY 2023) | Active |
| Pharmaxy Medicines Private Limited U21002MP2023PTC068366 | Director | 26 Oct 2023 | 2023 | Active |
Board colleagues of Chandrawati Rai
| Name | DIN | Company | Designation |
|---|---|---|---|
| Uday Kumar Rai | 06406941 | Chandra Devbuild Private Limited , Pharmaxy Medicines Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chandrawati Rai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chandrawati Rai
Chandrawati Rai currently holds 2 directorships: Chandra Devbuild Private Limited (Director, since 19 Oct 2015, revenue ₹9.27 Cr (FY 2023)); Pharmaxy Medicines Private Limited (Director, since 26 Oct 2023).
Chandrawati Rai was first appointed on 19 Oct 2015 as Director at Chandra Devbuild Private Limited. The most recent appointment on record is 26 Oct 2023 at Pharmaxy Medicines Private Limited.
The current boards of Chandrawati Rai's companies include Uday Kumar Rai (Chandra Devbuild Private Limited).